Clinical Trials · NCT04027023
Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Sciema UG
- Enrollment
- 9
- Start date
- Oct 2019
- Locations
- 2 sites, United States, Germany
- Primary endpoint
- impact of a temporary personalized poly-pharmaceutical treatment on the disease stage in patients with type 2 diabetes